×

Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase

  • US 8,338,594 B2
  • Filed: 12/01/2006
  • Issued: 12/25/2012
  • Est. Priority Date: 12/02/2005
  • Status: Expired due to Fees
First Claim
Patent Images

1. A compound of formula (I)

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×